Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, January 18, 2022.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Strong Downtrend (-100) - RARE is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, RARE continues to fall. Traders should use caution and set stops.
Is it time to buy, sell, or avoid RARE?
MarketClub looks at technical strength and momentum to determine if the timing is right for RARE.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for RARE
The long-term trend has been DOWN since Mar 5th, 2021 at 115.15
The intermediate-term trend has been DOWN since Jan 7th, 2022 at 77.31
The short-term trend has been DOWN since Jan 6th, 2022 at 80.24
Smart Scan Analysis for RARE
Based on our trend formula, RARE is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 70.73 | 70.84 | 67.63 | 67.67 | -4.38 |
| Prev. Close | Volume | Bid | Ask | Time |
| 72.05 | 262026 | 2022-01-18 15:59:59 |
| Year High | 90.98 | Year High Date | 2018-09-25 |
| Year Low | 41.67 | Year Low Date | 2018-02-09 |
| 52wk High | 175 | 52wk High Date | 2021-02-10 |
| 52wk Low | 68.2 | 52wk Low Date | 2022-01-14 |
| Average Volume | 427,798 | Shares Outstanding | 68,162 |
| Market Cap | 2,596M | Assets | 148,480,100M |
| Liabilities | 551,127,000M | P/E Ratio | -16.5725 |
| Volatility | 91.04 |